Back to Search
Start Over
Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain.
- Source :
-
Experimental diabesity research [Exp Diabesity Res] 2004 Jul-Sep; Vol. 5 (3), pp. 177-85. - Publication Year :
- 2004
-
Abstract
- The New Zealand obese (NZO) mouse strain shares with the related New Zealand black (NZB) strain a number of immunophenotypic traits. Among these is a high proportion of B-1 B lymphocytes, a subset associated with autoantibody production. Approximately 50% of NZO/HlLt males develop a chronic insulin-resistant type 2 diabetes syndrome associated with 2 unusual features: the presence of B lymphocyte-enriched peri-insular infiltrates and the development of anti-insulin receptor autoantibodies (AIRAs). To establish the potential pathogenic contributions of B lymphocytes and AIRAs in this model, a disrupted immunoglobulin heavy chain gene (Igh-6) congenic on the NZB/BlJ background was backcrossed 4 generations into the NZO/HlLt background and was then intercrossed to produce mice that initially segregated for wild-type versus the mutant Igh-6 allele and thus permitted comparison of syndrome development. A new flow cytometric assay (AIRA binding to transfected Chinese hamster ovary cells stably expressing mouse insulin receptor) showed IgM and IgG subclass AIRAs in serum from Igh-6 intact males, but not in Igh-6null male serum. However, the absence of B lymphocytes and antibodies distinguishing mutant from wild-type males failed to significantly affect diabetes-free survival. The Igh-6null males gained weight less rapidly than wild-type males, probably accounting for a retardation, but not prevention, of hyperglycemia. Thus, AIRA and the B-lymphocyte component of the peri-insulitis in chronic diabetics were not essential either to development of insulin resistance or to eventual pancreatic beta cell failure and loss. A new substrain, designated NZL, was generated by inbreeding Igh-6 wild-type segregants. Currently at the F10 generation, NZL mice exhibit the same juvenile-onset obesity as NZO/HlLt males, but develop type 2 diabetes at a higher frequency (> 80%). Also, unlike NZO/HlLt mice that are difficult to breed, the NZL/Lt strain breeds well and thus offers clear advantages to obesity/diabetes researchers.
- Subjects :
- Animals
B-Lymphocytes pathology
CHO Cells
Cricetinae
Cricetulus
Diabetes Mellitus, Type 2 pathology
Genes, Immunoglobulin genetics
Male
Mice
Mice, Inbred Strains
Mice, Knockout
Obesity genetics
Receptor, Insulin metabolism
Time Factors
Transfection
Autoantibodies metabolism
Diabetes Mellitus, Type 2 genetics
Diabetes Mellitus, Type 2 immunology
Receptor, Insulin immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1543-8600
- Volume :
- 5
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Experimental diabesity research
- Publication Type :
- Academic Journal
- Accession number :
- 15512785
- Full Text :
- https://doi.org/10.1080/15438600490478029